1. Home
  2. PRPL vs RVPH Comparison

PRPL vs RVPH Comparison

Compare PRPL & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPL
  • RVPH
  • Stock Information
  • Founded
  • PRPL 2010
  • RVPH 2006
  • Country
  • PRPL United States
  • RVPH United States
  • Employees
  • PRPL N/A
  • RVPH N/A
  • Industry
  • PRPL Home Furnishings
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • PRPL Consumer Discretionary
  • RVPH Health Care
  • Exchange
  • PRPL Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • PRPL 90.3M
  • RVPH 88.0M
  • IPO Year
  • PRPL N/A
  • RVPH N/A
  • Fundamental
  • Price
  • PRPL $1.02
  • RVPH $1.84
  • Analyst Decision
  • PRPL Buy
  • RVPH Strong Buy
  • Analyst Count
  • PRPL 3
  • RVPH 5
  • Target Price
  • PRPL $1.70
  • RVPH $11.40
  • AVG Volume (30 Days)
  • PRPL 581.0K
  • RVPH 1.6M
  • Earning Date
  • PRPL 03-11-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • PRPL N/A
  • RVPH N/A
  • EPS Growth
  • PRPL N/A
  • RVPH N/A
  • EPS
  • PRPL N/A
  • RVPH N/A
  • Revenue
  • PRPL $504,838,000.00
  • RVPH N/A
  • Revenue This Year
  • PRPL N/A
  • RVPH N/A
  • Revenue Next Year
  • PRPL $1.83
  • RVPH N/A
  • P/E Ratio
  • PRPL N/A
  • RVPH N/A
  • Revenue Growth
  • PRPL N/A
  • RVPH N/A
  • 52 Week Low
  • PRPL $0.75
  • RVPH $0.60
  • 52 Week High
  • PRPL $2.33
  • RVPH $4.50
  • Technical
  • Relative Strength Index (RSI)
  • PRPL 48.14
  • RVPH 47.68
  • Support Level
  • PRPL $0.99
  • RVPH $1.66
  • Resistance Level
  • PRPL $1.09
  • RVPH $2.14
  • Average True Range (ATR)
  • PRPL 0.08
  • RVPH 0.15
  • MACD
  • PRPL -0.02
  • RVPH -0.02
  • Stochastic Oscillator
  • PRPL 16.42
  • RVPH 36.73

About PRPL Purple Innovation Inc.

Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: